Creative Medical Technology Holdings Inc
CELZ
NASDAQ
Biotechnology
$1.22
USD
-0.02 (-1.61%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $8.17M
Volume 665.3K
Revenue
$3,000
TTM
-78.6%
YoY
Gross Margin
67%
TTM
+11.4%
YoY
Net Income
$-5.76M
TTM
+5.4%
YoY
Operating Cash Flow
$-5.59M
TTM
+6.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | -100.0% | — | 0.0% | -100.0% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 0.9 | 0.7 | 0.8 | 1.4 | 0.9 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 1.7 | 1.3 | 1.3 | 1.9 | 1.5 |
Operating Income | -1.7 | -1.3 | -1.3 | -1.9 | -1.5 |
EBITDA | -1.6 | -1.2 | -1.2 | -1.9 | -1.4 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
Income Before Income Taxes | -1.6 | -1.2 | -1.2 | -1.9 | -1.4 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -1.6 | -1.2 | -1.2 | -1.9 | -1.4 |
Consolidated Net Income / Loss | -1.6 | -1.2 | -1.2 | -1.9 | -1.4 |
Net Income Attributable to Common Shareholders | -1.6 | -1.2 | -1.2 | -1.9 | -1.4 |
Basic EPS | -$0.83 | -$0.48 | -$0.48 | -$0.79 | -$0.38 |
Diluted EPS | -$0.83 | -$0.48 | -$0.48 | -$0.79 | -$0.38 |
Basic Shares Outstanding | 2.0M | 2.6M | 2.6M | 2.4M | 3.7M |
Diluted Shares Outstanding | 2.0M | 2.6M | 2.6M | 2.4M | 3.7M |